In the future, all variants of TCF7L2, KCNQ1, and CDKAL1 could be genotyped to classify clusters of newly diagnosed type 2 diabetes (T2D) in large, multi-centre studies with long-term follow-up. The gene discussed is CDKAL1; the disease is type 2 diabetes mellitus.